Zonisade (zonisamide oral suspension), 100 mg/5 mL, is indicated as adjunctive therapy for the treatment of partial seizures in adults and pediatric patients aged 16 years and older.
$599.00
| Active Ingredient | Zonisamide |
|---|---|
| Indication | Epilepsy |
| Origin | United States of America |
| Packaging | 150 ml bottle |
| Storage Temperature | Controlled room temperature |
| Strength | 100mg/5ml |